↓ Skip to main content

Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial

Overview of attention for article published in BMC Cancer, August 2011
Altmetric Badge

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
57 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial
Published in
BMC Cancer, August 2011
DOI 10.1186/1471-2407-11-373
Pubmed ID
Authors

Michael Fiegl, Brigitte Mlineritsch, Michael Hubalek, Rupert Bartsch, Ursula Pluschnig, Günther G Steger

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
Korea, Republic of 1 2%
Unknown 54 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 23%
Student > Ph. D. Student 7 12%
Student > Bachelor 6 11%
Other 6 11%
Student > Doctoral Student 5 9%
Other 10 18%
Unknown 10 18%
Readers by discipline Count As %
Medicine and Dentistry 12 21%
Pharmacology, Toxicology and Pharmaceutical Science 6 11%
Biochemistry, Genetics and Molecular Biology 6 11%
Agricultural and Biological Sciences 5 9%
Nursing and Health Professions 3 5%
Other 10 18%
Unknown 15 26%